# Affinity Asset Advisors, LLC 13F Q2 2026: $2.2 billion

Affinity Asset Advisors, LLC reported $2.2 billion in 13F securities across 113 positions for the quarter ended June 30, 2026, in a holdings report filed August 13, 2026. Its largest holding was Roivant Sciences LTD at $133 million, 6.0% of the reported value. Since Q1 2026 it opened 26 new positions and exited 18.

SpecStream is the live web data engine for teams and agents. It reads the SEC's Form 13F data sets each quarter, and this page is that reading, keyed on the manager's CIK and the security's CUSIP. Ask for the managers or the holdings you track, and each new 13F filing arrives in your sheet, CRM, Slack or agent as the SEC publishes it.

- Quarter: Q2 2026, the quarter ended June 30, 2026
- Reported value: $2,212,480,490
- Positions: 113
- Filed: August 13, 2026
- Report type: 13F holdings report
- CIK: 1773195
- Form 13F file number: 028-20754
- Business address: 450 Park Avenue Suite 1403, New York, NY 10022
- SEC filing: [0001011438-26-000516](https://www.sec.gov/Archives/edgar/data/1773195/000101143826000516/0001011438-26-000516-index.htm)
- Investment adviser record: [Form ADV on SpecStream](https://specstream.ai/data/investment-advisers/firm/affinity-asset-advisors-llc-312788)

## Top 25 holdings by value

The largest of 113 positions by reported value at the end of the quarter ended June 30, 2026. Put and call options are marked in the class. Change is in shares or principal against the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value | Change since Q1 2026 |
| --- | --- | --- | --- | --- |
| [Roivant Sciences LTD](https://specstream.ai/data/institutional-holders/roivant-sciences-ltd-g76279101) | SHS | 3,750,000 | $132.7 million | +950,000 |
| [Apogee Therapeutics Inc](https://specstream.ai/data/institutional-holders/apogee-therapeutics-inc-03770n101) | COM | 987,000 | $131 million | -297,926 |
| [Spyre Therapeutics Inc](https://specstream.ai/data/institutional-holders/spyre-therapeutics-inc-00773j202) | COM NEW | 1,279,134 | $113.6 million | No change |
| [Xenon Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/xenon-pharmaceuticals-inc-98420n105) | COM | 1,595,000 | $96.3 million | -80,000 |
| [Erasca Inc](https://specstream.ai/data/institutional-holders/erasca-inc-29479a108) | COM | 5,250,000 | $96.2 million | -100,000 |
| [Insmed Inc](https://specstream.ai/data/institutional-holders/insmed-inc-457669307) | COM PAR $.01 | 650,000 | $69.3 million | +170,000 |
| [Praxis Precision Medicines I](https://specstream.ai/data/institutional-holders/praxis-precision-medicines-i-74006w207) | COM NEW | 185,000 | $61.9 million | +15,000 |
| [Alkermes PLC](https://specstream.ai/data/institutional-holders/alkermes-plc-g01767105) | SHS | 1,125,000 | $58.9 million | -225,000 |
| [Oruka Therapeutics Inc](https://specstream.ai/data/institutional-holders/oruka-therapeutics-inc-687604108) | COM | 590,000 | $56.2 million | +90,327 |
| [Anaptysbio Inc](https://specstream.ai/data/institutional-holders/anaptysbio-inc-032724106) | COM | 826,109 | $55.8 million | -113,891 |
| [Avalo Therapeutics Inc](https://specstream.ai/data/institutional-holders/avalo-therapeutics-inc-05338f306) | COM NEW | 2,900,000 | $53.6 million | +1,559,160 |
| [Cytokinetics Inc](https://specstream.ai/data/institutional-holders/cytokinetics-inc-23282w605) | COM NEW | 550,000 | $46.9 million | -150,483 |
| [Revolution Medicines Inc](https://specstream.ai/data/institutional-holders/revolution-medicines-inc-76155x100) | COM | 250,000 | $46.8 million | +150,000 |
| [Abivax SA](https://specstream.ai/data/institutional-holders/abivax-sa-00370m103) | SPONSORED ADS | 330,000 | $44 million | -75,000 |
| [First Tracks Biotherapeutics](https://specstream.ai/data/institutional-holders/first-tracks-biotherapeutics-337185102) | ORD SHS | 2,032,012 | $40.9 million | New |
| [Dianthus Therapeutics Inc](https://specstream.ai/data/institutional-holders/dianthus-therapeutics-inc-252828108) | COM | 400,000 | $39 million | +50,000 |
| [Sutro Biopharma Inc](https://specstream.ai/data/institutional-holders/sutro-biopharma-inc-869367201) | COM SHS | 1,172,487 | $38.9 million | +102,968 |
| Moderna Inc | COM (put) | 500,000 | $35 million | New |
| [Nuvalent Inc](https://specstream.ai/data/institutional-holders/nuvalent-inc-670703107) | COM | 275,000 | $34 million | -25,000 |
| [Trevi Therapeutics Inc](https://specstream.ai/data/institutional-holders/trevi-therapeutics-inc-89532m101) | COM | 1,800,172 | $33.6 million | -200,000 |
| Moderna Inc | COM (call) | 475,000 | $33.3 million | -325,000 |
| ARK ETF TR | GENOMIC REV ETF (call) | 750,000 | $31.5 million | New |
| [Ovid Therapeutics Inc](https://specstream.ai/data/institutional-holders/ovid-therapeutics-inc-690469101) | COM | 10,144,562 | $27.3 million | -491,756 |
| [Lexeo Therapeutics Inc](https://specstream.ai/data/institutional-holders/lexeo-therapeutics-inc-52886x107) | COM | 5,807,611 | $27 million | +757,400 |
| [Celldex Therapeutics Inc New](https://specstream.ai/data/institutional-holders/celldex-therapeutics-inc-new-15117b202) | COM NEW | 700,000 | $26 million | +200,000 |

## New positions in Q2 2026

26 positions not in the filing for the quarter ended March 31, 2026. The 25 largest are shown.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [First Tracks Biotherapeutics](https://specstream.ai/data/institutional-holders/first-tracks-biotherapeutics-337185102) | ORD SHS | 2,032,012 | $40.9 million |
| Moderna Inc | COM (put) | 500,000 | $35 million |
| ARK ETF TR | GENOMIC REV ETF (call) | 750,000 | $31.5 million |
| Eli Lilly & Co | COM (call) | 20,000 | $24 million |
| [Ideaya Biosciences Inc](https://specstream.ai/data/institutional-holders/ideaya-biosciences-inc-45166a102) | COM | 400,000 | $14.9 million |
| [Odyssey Therapeutics Inc](https://specstream.ai/data/institutional-holders/odyssey-therapeutics-inc-67613t104) | COMMON STOCK | 766,346 | $14.3 million |
| Omeros Corp | COM (put) | 1,411,300 | $13.4 million |
| Alkermes PLC | SHS (call) | 250,000 | $13.1 million |
| [Uniqure NV](https://specstream.ai/data/institutional-holders/uniqure-nv-n90064101) | SHS | 175,000 | $8.1 million |
| [Ascendis Pharma A/S](https://specstream.ai/data/institutional-holders/ascendis-pharma-a-s-k08588103) | ORD SHS | 30,000 | $8 million |
| Evommune Inc | COM SHS (put) | 500,100 | $6.6 million |
| [Assembly Biosciences Inc](https://specstream.ai/data/institutional-holders/assembly-biosciences-inc-045396207) | COM NEW | 190,000 | $5.2 million |
| [Hemab Therapeutics Hldgs Inc](https://specstream.ai/data/institutional-holders/hemab-therapeutics-hldgs-inc-423494103) | COM SHS | 138,030 | $5.1 million |
| [Research Alliance Corp III](https://specstream.ai/data/institutional-holders/research-alliance-corp-iii-g75226103) | ORD SHS CL A | 370,000 | $4 million |
| [Amanat Acquisition Corp](https://specstream.ai/data/institutional-holders/amanat-acquisition-corp-g0375m101) | CL A ORD | 375,000 | $3.8 million |
| [Biohaven LTD](https://specstream.ai/data/institutional-holders/biohaven-ltd-g1110e107) | COM | 250,000 | $3.7 million |
| [Faeth Therapeutics Inc](https://specstream.ai/data/institutional-holders/faeth-therapeutics-inc-81728a207) | COM NEW | 144,404 | $3.6 million |
| [Celcuity Inc](https://specstream.ai/data/institutional-holders/celcuity-inc-15102kab6) | NOTE 0.250% 8/0 (principal) | 2,000,000 | $2.3 million |
| [Jatt II Acquisition Corp](https://specstream.ai/data/institutional-holders/jatt-ii-acquisition-corp-g50765109) | ORD SHS | 200,000 | $2.3 million |
| [Neumora Therapeutics Inc.](https://specstream.ai/data/institutional-holders/neumora-therapeutics-inc-640979100) | COM | 1,070,651 | $1.8 million |
| [Amylyx Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/amylyx-pharmaceuticals-inc-03237h101) | COM | 98,999 | $1.8 million |
| [Spruce Biosciences Inc](https://specstream.ai/data/institutional-holders/spruce-biosciences-inc-85209e208) | COM NEW | 30,000 | $1.6 million |
| Summit Therapeutics Inc | COM (call) | 100,000 | $1.5 million |
| [Eikon Therapeutics Inc](https://specstream.ai/data/institutional-holders/eikon-therapeutics-inc-282564103) | COM | 98,001 | $1.3 million |
| [Engene Therapeutics Inc](https://specstream.ai/data/institutional-holders/engene-therapeutics-inc-29286x101) | COM | 600,000 | $1 million |

## Positions exited in Q2 2026

18 positions in the filing for the quarter ended March 31, 2026 and not in this one, with the shares and value reported then.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| State STR SPDR S&P 500 ETF T | TR UNIT (put) | 200,000 | $130.1 million |
| Centessa Pharmaceuticals PLC | SPONSORED ADS | 1,400,000 | $55.6 million |
| Arcellx Inc | COMMON STOCK | 362,764 | $41.7 million |
| Terns Pharmaceuticals Inc | COM | 562,631 | $29.7 million |
| Ascendis Pharma A/S | SPONSORED ADR | 95,000 | $21.7 million |
| Bristol-Myers Squibb Co | COM (call) | 300,000 | $18.2 million |
| [Bridgebio Pharma Inc](https://specstream.ai/data/institutional-holders/bridgebio-pharma-inc-10806x102) | COM | 150,000 | $11.1 million |
| [Wave Life Sciences LTD](https://specstream.ai/data/institutional-holders/wave-life-sciences-ltd-y95308105) | SHS | 1,401,727 | $10.2 million |
| Revolution Medicines Inc | COM (put) | 100,000 | $9.7 million |
| Immunitybio Inc | COM (put) | 1,250,000 | $9.6 million |
| Celcuity Inc | NOTE 2.750% 8/0 (principal) | 3,000,000 | $7.3 million |
| Novo-Nordisk a S | ADR (call) | 175,000 | $6.4 million |
| Dianthus Therapeutics Inc | COM (call) | 50,000 | $4.2 million |
| Engene Holdings Inc | COM | 610,370 | $4.2 million |
| CG Oncology Inc | COM (call) | 60,000 | $4.1 million |
| Celcuity Inc | COM (call) | 30,000 | $3.4 million |
| [Corcept Therapeutics Inc](https://specstream.ai/data/institutional-holders/corcept-therapeutics-inc-218352102) | COM | 50,000 | $2 million |
| Kezar Life Sciences Inc | COM NEW | 229,076 | $1.7 million |

## Also on SpecStream

- [Affinity Asset Advisors, LLC Form 13F filing on EDGAR](https://www.sec.gov/Archives/edgar/data/1773195/000101143826000516/0001011438-26-000516-index.htm)
- [Affinity Asset Advisors, LLC investment adviser record (Form ADV)](https://specstream.ai/data/investment-advisers/firm/affinity-asset-advisors-llc-312788)
- [Largest 13F filers in New York](https://specstream.ai/data/institutional-holdings/state/new-york)
- [Largest institutional managers by 13F value](https://specstream.ai/data/institutional-holdings)
- [Most widely held securities in 13F filings](https://specstream.ai/data/institutional-holders)

Source: [the SEC's Form 13F data sets](https://www.sec.gov/data-research/sec-markets-data/form-13f-data-sets). Public data published by the US Securities and Exchange Commission (US government work). Managers report these holdings themselves in Form 13F, and the SEC does not check or guarantee them. Form 13F lists long positions in US listed equities, some options and convertible notes held at the end of the quarter, and leaves out short positions, cash, most bonds and holdings below the reporting threshold. Values are market values in US dollars as the manager filed them. A manager can ask the SEC to keep some positions confidential for a time. This page uses SEC data and is not endorsed or certified by the SEC.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in New York, New York

- [Smoothie and juice bars in New York, New York](https://specstream.ai/data/businesses/smoothie-and-juice-bars/new-york-new-york-united-states)
- [Environmental services in New York, New York](https://specstream.ai/data/businesses/environmental-services/new-york-new-york-united-states)
- [Speech therapy clinics in New York, New York](https://specstream.ai/data/businesses/speech-therapy-clinics/new-york-new-york-united-states)
- [Fabric wholesalers in New York, New York](https://specstream.ai/data/businesses/fabric-wholesalers/new-york-new-york-united-states)
- [Structural engineering firms in New York, New York](https://specstream.ai/data/businesses/structural-engineering-firms/new-york-new-york-united-states)
- [Financial services firms in New York, New York](https://specstream.ai/data/businesses/financial-services-firms/new-york-new-york-united-states)
